000 01519 a2200385 4500
005 20250516132948.0
264 0 _c20130409
008 201304s 0 0 jpn d
022 _a0387-5911
024 7 _a10.11150/kansenshogakuzasshi.86.734
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aToda, Hirofumi
245 0 0 _a[Clinical microbiological investigation of vancomycin intermediate Staphylococcus aureus during glycopeptide therapy].
_h[electronic resource]
260 _bKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
_cNov 2012
300 _a734-40 p.
_bdigital
500 _aPublication Type: Case Reports; English Abstract; Journal Article
650 0 4 _aAged
650 0 4 _aGlycopeptides
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethicillin-Resistant Staphylococcus aureus
_xdrug effects
650 0 4 _aMicrobial Sensitivity Tests
650 0 4 _aTeicoplanin
_xtherapeutic use
650 0 4 _aVancomycin
_xpharmacology
700 1 _aYamaguchi, Toshihiro
700 1 _aMiyara, Takayuki
700 1 _aHisato, Akihiro
700 1 _aMatsushima, Tomohide
700 1 _aShimada, Takahiro
700 1 _aSano, Hiroyuki
700 1 _aNakae, Kenichi
700 1 _aKamisako, Toshinori
773 0 _tKansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases
_gvol. 86
_gno. 6
_gp. 734-40
856 4 0 _uhttps://doi.org/10.11150/kansenshogakuzasshi.86.734
_zAvailable from publisher's website
999 _c22464808
_d22464808